Winton Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Winton Group's CTKB Position: Q3 2026 in Review
Winton Group opened a new position in Cytek Biosciences (CTKB) in Q3 2026: 14,067 shares worth $83.8K. The stake represents ﹤0.01% of the portfolio and ranks #1044 among its holdings.
150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- Winton Group held 14,067 shares of Cytek Biosciences worth $83.8K as of Q3 2026.
- Cytek Biosciences was a new Winton Group position in Q3 2026.
- Cytek Biosciences made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1044 holding.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.